DCSZ11 as a Monotherapy and in Combination in Patients With Advanced or Metastatic Solid Tumors
Recruiting now · Phase 1
Conditions studied: Advanced or Metastatic Solid Tumors
In brief
This is a multicenter, open-label, Phase 1 study to assess the effects of DCSZ11 as a monotherapy and in combination in patients with advanced or metastatic solid tumors. The study consists of an Escalation Phase (Phase 1a) and a Dose Expansion/Optimization Phase (Phase 1b).
Key facts
- Study ID
- NCT05785754
- Run by
- DynamiCure Biotechnology
- People needed
- 320
- Starts
- 2023-06-28
- Expected to finish
- 2026-12-01
- Last updated by the study team
- 2025-06-26
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- National Taiwan University Hospital — Taipei, Taiwan (enrolling)
- Mayo Clinic — Phoenix, Arizona, United States (enrolling)
- HonorHealth — Scottsdale, Arizona, United States (enrolling)
- University of Colorado — Aurora, Colorado, United States (enrolling)
- Sarah Cannon Research Institute Denver Healthone — Denver, Colorado, United States (enrolling)
- Yale Cancer Center — New Haven, Connecticut, United States (enrolling)
- Mayo Clinic — Jacksonville, Florida, United States (enrolling)
- University of Miami — Miami, Florida, United States (enrolling)
- John Hopkins Sidney Kimmel Comprehensive Cancer Center — Baltimore, Maryland, United States (enrolling)
- Cha University Bundang Medical Center — Gyeonggi-do, South Korea (enrolling)
- Severance Hospital, Yonsei University Health System — Seoul, South Korea (enrolling)
- Kaohsiung Medical University Chung-ho Memorial Hospital — Kaohsiung City, Taiwan (enrolling)
- National Cheng Kung University Hospital — Tainan, Taiwan (enrolling)
- Taipei Veterans General Hospital — Taipei, Taiwan (enrolling)
- University of Alabama — Birmingham, Alabama, United States (enrolling)
- Mayo Clinic — Rochester, Minnesota, United States (enrolling)
- MonteFiore — The Bronx, New York, United States (enrolling)
- Ohio State University — Columbus, Ohio, United States (enrolling)
- SCRI Oncology Partners — Nashville, Tennessee, United States (enrolling)
- Scientia Clinical Research — Randwick, New South Wales, Australia (enrolling)
- St Vincent's Hospital — Sydney, New South Wales, Australia (enrolling)
- Southern Oncology Clinical Research Unit (SOCRU) — Bedford Park, South Australia, Australia (enrolling)
- The Queen Elizabeth Hospital (TQEH) — Woodville South, South Australia, Australia (enrolling)
- Monash Health — Clayton, Victoria, Australia (enrolling)
- Linear Clinical Research Limited — Nedlands, Western Australia, Australia (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.